Oncology & Cancer

Trial shows promise for new antibody cancer treatment

The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.

Oncology & Cancer

Cellular 'fingerprint' may offer early warning of cancer risk

For nearly every disease, age is a major risk factor, and cancer is no exception. Between the ages of 25 and 65, an individual's risk of developing cancer skyrockets by 4,000%. A new study explores a "fingerprint" in cells ...

Oncology & Cancer

How skin cancer virus outcompetes host cell replication

University of Pittsburgh researchers have shown for the first time how Merkel cell polyomavirus (MCV), which causes an aggressive skin cancer called Merkel cell carcinoma, initiates DNA replication in host cells.

Oncology & Cancer

Researchers target mutation that leads to pancreatic cancer

After 30 years of discouraging results in attempting to develop drugs to inhibit a mutated protein associated with some of the more challenging cancers to treat, research on RAS proteins is booming.

Oncology & Cancer

Fecal transplants show promise in improving melanoma treatment

In a world-first clinical trial published in the journal Nature Medicine, a multi-center study from Lawson Health Research Institute, the Centre hospitalier de l'Université de Montréal (CHUM) and the Jewish General Hospital ...

page 9 from 40